$HAS Stock Attracts Wall Street Bullish Signals as Analysts Raise Overweight Rating

Wall Street sentiment toward $HAS has shifted decisively positive following Morgan Stanley’s latest “Overweight” rating, marking a significant endorsement from one of the Street’s most influential research teams.

Analyst Consensus Points to Upside

The recent overweight rating from Morgan Stanley adds to a growing chorus of bullish calls. Across the past six months, a total of 5 major financial institutions have issued buy-equivalent ratings on the stock, with zero sell recommendations—a stark indicator of institutional confidence.

The analyst consensus reveals strong alignment among major players:

• Morgan Stanley’s “Overweight” call (07/24/2025) sets the tone for positive momentum
• B of A Securities maintained conviction with a buy rating (07/17/2025)
• Goldman Sachs analysts lined up behind buy recommendations (07/01/2025)
• Citigroup backed the thesis with a buy rating (06/16/2025)
• Roth MKM initiated coverage with bullish positioning (02/21/2025)

Price Targets Suggest 15-20% Upside Potential

Financial analysts have staked out ambitious targets for $HAS, with seven research firms publishing price objectives in recent months. The median price target stands at $82.0, but the range reveals interesting nuance among the Street’s experts.

Recent price target calls include:

• Morgan Stanley’s Megan Alexander set a $85.0 target, implying meaningful upside
• B of A Securities’ Alexander Perry pushed higher with a $90.0 objective on 07/17/2025
• Goldman Sachs analyst Stephen Laszczyk targeted $85.0, matching Morgan Stanley’s call
• Citigroup’s James Hardiman offered a more conservative $79.0 target
• DA Davidson’s Keegan Cox positioned at $75.0 on 05/15/2025
• Roth MKM’s Eric Handler settled on $82.0, anchoring near the median

Institutional Money Flows Paint Mixed Picture

While analyst sentiment runs uniformly bullish, the institutional hedge fund landscape shows more complexity. Q1 2025 saw substantial portfolio repositioning, with 313 institutional investors adding shares while 286 trimmed positions—suggesting a transition period in holdings.

The largest institutional moves reveal strategic reallocation:

• Citadel Advisors made the most aggressive overweight bet, adding 2.4 million shares (+553%) for approximately $148.3 million in capital deployment
• FMR LLC ramped exposure significantly with a 1.25 million share increase, representing $77.1 million deployed
• Pacer Advisors and Kovitz Investment Group executed substantial exits, reducing exposure by 99.7% and 75.4% respectively
• Goldman Sachs and Swedbank reduced their positions, signaling selective profit-taking among traditional investors

Congressional Activity Remains Minimal

Legislative trading of $HAS has been sparse, with only 1 transaction recorded over the past six months—a sale of up to $15,000 by Representative Julie Johnson on 04/01. This limited government trading activity suggests the stock exists primarily in the institutional and retail investment universe.

The overweight rating from Morgan Stanley, combined with uniform buy recommendations and price targets clustering around $82-90, positions $HAS as a stock with meaningful bullish conviction among professional investors. However, the divergent hedge fund positioning underscores that consensus enthusiasm masks selective institutional positioning beneath the surface.